Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2025-12-24 @ 11:28 PM
NCT ID:
NCT04226456
Eligibility Criteria:
Inclusion Criteria:
* ≥ 18-year-old
* Patients suffering from a neoplastic disease for which treatment protocol includes Cisplatin.
Exclusion Criteria:
* Women of childbearing potential pregnant or with intention to become pregnant within the trial duration
* Women who are breastfeeding
* Pathological findings on otoscopy that do not allow safe intratympanic drug delivery.
* Conductive hearing loss \> 20dBHL
* Meniere disease
* Medical history of sudden hearing loss
* Sensoryneural Hearing loss (SNHL) with mean ≥ 40dbHL Pure Tonal Audiometry (PTA)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04226456
Study Brief:
Protocol Section:
NCT04226456